Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biomind Labs Inc N.BMND

Alternate Symbol(s):  BMNDF

Biomind Labs Inc. is a biotech research and development company. It is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of key endogenous substances which are occurring in the human body and an organic compound that includes many neurotransmitters for treating a range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors. 5-MeO-DMT is a powerful psychedelic tryptamine. Under the 5-MeO-DMT Program, it is focused on two drug candidates: BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.


NEO:BMND - Post by User

Bullboard Posts
Comment by Veteran1on Dec 07, 2009 8:34pm
373 Views
Post# 16562855

RE: RE: $1.60 is where this will end up getting ta

RE: RE: $1.60 is where this will end up getting taTo add my 2 cents in,

From a good contact , in an orderly liquidation the value on the assets in question could be worth $2.40 is the price that could be realized in 2-3 years. So at $1.60 that would imply 50% upside profit that could be achieved for the buyers to buy this outright if taken private. 50% return in 2 years woudl be a great safer investment if the end result is basically just unlocking value. 3 years not quite as great , so at $1.60 I think that would be a good takeout offer for the buyers.

At $2.00 take put price and if assets worth $2.40 that implies only 20% upsdie in 2 years +  . Not enough to chase after, so will think $1.60 is a good base range give or take a dime or so..



Bullboard Posts